
ACS Medicinal Chemistry Letters, Год журнала: 2025, Номер 16(4), С. 538 - 539
Опубликована: Апрель 1, 2025
Provided herein are novel compounds as NLRP3 inhibitors, pharmaceutical compositions, use of such in treating asthma or COPD, and processes for preparing compounds.
Язык: Английский